期刊文献+

窒息新生儿体内三大抗凝因子活性的研究 被引量:1

The Study of the Activity of Plasma Protein C Protein S and Antithrombin-Ⅲ in Asphyctic Neonates
下载PDF
导出
摘要 目的:探讨窒息缺氧对新生儿血浆蛋白C、S、抗凝血酶Ⅲ(AT-Ⅲ)活性的影响。方法:我院新生儿科于2004年9月至2005年12月采用发色底物法分别测定出生时、3d、7d的56例窒息新生儿血浆蛋白C、抗凝血酶Ⅲ活性,用凝固酶法测定蛋白S的活性。正常对照组为同期出生的健康新生儿51例。结果:出生时、3d窒息组与正常对照组血浆蛋白C、S、抗凝血酶Ⅲ活性均有不同程度下降,窒息组下降明显,其差异有非常显著意义(P均<0.01)。结论:窒息新生儿3d内血浆蛋白C、S、抗凝血酶Ⅲ活性明显降低,并与窒息的程度有关,血浆蛋白C、S、抗凝血酶Ⅲ降低明显窒息愈重,常合并多个组织器官损害,但未达到DIC标准。 Objective: To explore the dynamic changes of protein C, Protein S and antithrombin Ⅲ in asphyctic neonates. Method: From Sep. 2004 to Dec. 2005, respectively, on the time of being born 3rd day and 7th day, the activity of protein C and AT - Ⅲ of 56 cases with asphyctic neonates and 51 cases normal newborn infants, were detected by illuminant substrate method, while protein S was detected by coagulatire method. Result: The activity of protein C, protein S and AT - Ⅲ on the time of being born and the third, the seventh day reduced in all observed newborn infants, while, the group of asphyctic neonates was more significandy lower than the normal new born infants. There was no significant difference between the two groups on the 7th day. Conclusion : The present data suggests that the changes of the protein C, protein S and AT - Ⅲ in 3 days are related to severity of asphyxia, the more severe asphyxia is, the more lower the activity of protein C protein S and AT - Ⅲ, usually, combined with the injury of multi - organs, while it has not been reached the standards of DIC.
作者 李小明
出处 《河北医学》 CAS 2007年第12期1250-1253,共4页 Hebei Medicine
关键词 新生儿 蛋白质C 蛋白质S 抗凝血酶Ⅲ Asphyxia Newborn Protein C Protein S Antithrombin - Ⅲ
  • 相关文献

参考文献4

二级参考文献71

  • 1许植之,新生儿呼吸系统疾病学,1993年,352页
  • 2王永友,儿科危重病症,1991年,268页
  • 3韩玉昆,中华儿科杂志,1990年,28卷,31页
  • 4Warren BL,Eid A,Singer P,et al.Caring for the critically ill patient.High-dose antithrombin III in severe sepsis:a randomized controlled trial[J].JAMA,2001,286(15):1869-1878.
  • 5Enkhbaatar P,Okajima K,Murakami K,et al.Recombinant tissue factor pathway inhibitor reduced lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activity[J].Am J Respir Crit Care Med,2000,162(5):1752-1759.
  • 6Gando S,Kameue T,Morimoto Y,et al.Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis[J].Crit Care Med,2002,30(8):1729-1734.
  • 7Franco RF,de Jonge E,Dekkers PE,et al.The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia:relationship with activated of coagulation[J].Blood,2000,96(2):554-559.
  • 8Welty-Wolf KE,Carraway MS,Miller DL,et al.Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons[J].Am J Respir Crit Care Med,2001,164(10):1988-1996.
  • 9Camerota AJ,Creasey AA,Patla V,et al.Delayed treatment with recombinant human tissue factor pathway inhibitor improves survival in rabbits with Gram-negative peritonitis[J].J Infect Dis,1998,177(3):668-676.
  • 10Opal SM,Palardy JE,Parejo NA,et al.The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis[J].Crit Care Med,2001,29(1):13-17.

共引文献40

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部